United States:
Major Questions Remain In Wake Of Trump Drug Pricing Executive Orders
13 October 2020
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
This post is a little different. Several of my colleagues
- Reed Smith attorneys Robert J. Hill, Joseph W. Metro, Kevin M. Madagan, Andrew Y. Lu, Sung W. Park, Janine R. Tougas - wrote a client alert on the four recent executive orders
that concerned pharmaceutical pricing. We had thought
about doing that ourselves, but it was too far from our product
liability sweet spot. When we read this alert, though, we
understood (well, about as well as anyone can understand this
mess). So, even though we don't ordinarily link to
branded law firm posts, in this one instance we're making an
exception. We think our readers will find the content of this
alert useful, and it's better than anything we could have put
together ourselves. So, please take a minute to read their assessment.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Consumer Protection from United States
Dark Chocolate And Heavy Metals
Holland & Knight
In December 2022, Consumer Reports published a study on lead and cadmium in dark chocolate. Dark chocolate came into vogue when studies showed antioxidants in it may have health benefits.
FTC Updates (April 8 – April 12, 2024)
Crowell & Moring LLP
The FTC kept busy through the week of the ABA Antitrust Spring Meeting including an appearance by Chair Lina Khan at the Spring Meeting on an antitrust enforcement panel.
No Asbestos In Cosmetic Talc Products Says FDA
Duane Morris LLP
On April 5, 2024 the US Food and Drug Administration confirmed that its third-party testing of cosmetic talc products for 2023 identified no traces of asbestos in any of the 50 cosmetic samples tested.